跳至主要内容
临床试验/NCT05402839
NCT05402839招募中不适用

Molecular Genetics Study on Screening of Malignant Hyperthermia Susceptible Individuals

Peking University Third Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
1
主要终点
Whole exome sequencing

研究概览

简要总结

This study intends to target patients who underwent surgery under general anesthesia during the study period and developed malignant hyperthermia during or after surgery. Therefore, the total sample size was estimated to be about 50 people based on the past incidence of this rare disease. Every year, about 20 patients and their families who developed malignant hyperthermia during or after surgery will participate in this nationwide study (estimated by the current incidence of malignant hyperthermia), and about 1-5 patients will be admitted to Peking University Third Hospital participate in this research. Relevant specimens were collected from malignant hyperthermia (MH) patients and their family members for genetic analysis to determine the mutation of MH-related pathogenic gene loci.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
0 Years 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing surgery under general anesthesia during the study period developed malignant hyperthermia during or after surgery.

排除标准

  • Malignant hyperthermia was ruled out by later treatment and diagnosis;
  • The patient or family member refuses to be recruited.

结局指标

主要结局

Whole exome sequencing

时间窗: immediately after MH was diagnosed

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Guo Xiangyang

Chief of the department of anesthesiology

Peking University Third Hospital

研究点 (1)

Loading locations...

相似试验